Authors
Latest:
Risks and management of diabetic retinopathy in paediatric patientsDiabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.
Latest:
The impact of landmark studies on clinical practice in glaucomaLandmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
Latest:
Landscape of genetic therapies for USH2A-related retinitis pigmentosaIncreasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.
Latest:
Assessing barriers to retinal care during a pandemicA global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Latest:
The shifting landscape of conjunctival hyperemiaEuropean patients navigate new therapies and market change-ups
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
Rethinking race as a risk factor for glaucomaSocial determinants of health challenge our existing expectations
Latest:
Shining new light on ocular surface careLow-level light therapy for dry eye disease and chalazion
Latest:
Keratoconus: Intrastromal implantation of fresh human lenticulesStromal regeneration seems possible in patients with keratoconus.
Latest:
Paying attention to ocular surface disease preoperatively mattersLook for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
Latest:
Refining what clinicians see and treat in outer retinal disease with Christine Curcio, PhDChristine A. Curcio, PhD, shares an update on histology and its critical role in advancing <3 μm optical coherence tomography interpretation
Latest:
The “fourth dimension” of home monitoringA longitudinal, AI-based approach to fluid quantification
Latest:
Understanding the molecular mechanisms underlying cataract developmentA greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.
Latest:
For younger patients with mid-range myopia, consider phakic IOLsThe implantable lenses can offer an advantage over laser surgery
Latest:
Ruth Hogg, PhD, says NICOLA data emphasise the value of multicolor imagesProf Hogg presented a wide breadth of research at the International SPECTRALIS Symposium
Latest:
How to use topography-guided laser procedures to treat keratoconusTopography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.
Latest:
Gereon Hüttmann, PhD, introduces holographic OCT to a new audienceThe new technology will be crucial to imaging retinal function in the future, Prof Hüttmann predicted at the International SPECTRALIS Symposium
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Extended depth-of-field IOLs: Clarification of current nomenclatureClinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to as ‘hybrid IOLs’.
Latest:
The CHAMP clinical trial and NVK002 for controlling paediatric myopiaDetermining the medication’s safety and efficacy for paediatric patients
Latest:
Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditionsClinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Latest:
A new route to reducing IOPTo date, the suprachoroidal space has not been a feasible route to reduce intraocular pressure in glaucoma. A new device promises to change that.
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Surgical management of posterior uveitis in childrenVitrectomy is a tool that can help surgeons curb complications
